{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:55:35Z","timestamp":1769630135965,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009526","name":"Amrita Vishwa Vidyapeetham University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009526","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s42000-023-00445-7","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T09:05:18Z","timestamp":1679562318000},"page":"311-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cost-effective genotyping for classical congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) in resource-poor settings: multiplex ligation probe amplification (MLPA) with\/without sequential next-generation sequencing (NGS)"],"prefix":"10.1007","volume":"22","author":[{"given":"Ana","family":"Monteiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2678-8847","authenticated-orcid":false,"given":"Praveen V.","family":"Pavithran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuprasad","family":"Puthukulangara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha","family":"Bhavani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheela","family":"Nampoothiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhanya","family":"Yesodharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reshma","family":"Kumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"445_CR1","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1210\/jc.2009-2631","volume":"95","author":"PW Speiser","year":"2010","unstructured":"Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP et al (2010) Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95:4133\u20134160. https:\/\/doi.org\/10.1210\/jc.2009-2631","journal-title":"J Clin Endocrinol Metab"},{"key":"445_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/00008480-199708000-00018","volume":"9","author":"S Pang","year":"1997","unstructured":"Pang S, Shook MK (1997) Status of neonatal screening for congenital adrenal hyperplasia. Curr Opin Pediatr 9:419\u2013423. https:\/\/doi.org\/10.1097\/00008480-199708000-00018","journal-title":"Curr Opin Pediatr"},{"key":"445_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0889-8529(08)70017-3","volume":"30","author":"BL Therrell","year":"2001","unstructured":"Therrell BL (2001) Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 30:15\u201330. https:\/\/doi.org\/10.1016\/s0889-8529(08)70017-3","journal-title":"Endocrinol Metab Clin North Am"},{"key":"445_CR4","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s12098-018-2645-9","volume":"85","author":"ICMR Task Force on Inherited Metabolic Disorders","year":"2018","unstructured":"ICMR Task Force on Inherited Metabolic Disorders (2018) Newborn screening for congenital hypothyroidism and congenital adrenal hyperplasia. Indian J Pediatr 85:935\u2013940. https:\/\/doi.org\/10.1007\/s12098-018-2645-9","journal-title":"Indian J Pediatr"},{"key":"445_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.beem.2008.10.014","volume":"23","author":"N Krone","year":"2009","unstructured":"Krone N, Arlt W (2009) Genetics of congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 23:181\u2013192. https:\/\/doi.org\/10.1016\/j.beem.2008.10.014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"445_CR6","doi-asserted-by":"publisher","first-page":"12147","DOI":"10.1074\/jbc.274.17.12147","volume":"274","author":"Z Yang","year":"1999","unstructured":"Yang Z, Mendoza AR, Welch TR, Zipf WB, Yu CY (1999) Modular variations of the human major histocompatibility complex class III genes for serine\/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module). A mechanism for gene deletions and disease associations. J Biol Chem 274:12147\u201312156. https:\/\/doi.org\/10.1074\/jbc.274.17.12147","journal-title":"J Biol Chem"},{"key":"445_CR7","doi-asserted-by":"publisher","first-page":"20916","DOI":"10.1016\/S0021-9258(17)45304-X","volume":"265","author":"MT Tusie-Luna","year":"1990","unstructured":"Tusie-Luna MT, Traktman P, White PC (1990) Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. J Biol Chem 265:20916\u201320922","journal-title":"J Biol Chem"},{"key":"445_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2165\/00129785-200101020-00003","volume":"1","author":"PW Speiser","year":"2001","unstructured":"Speiser PW (2001) Molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia: implications for genetic counseling. Am J Pharmacogenomics 1:101\u2013110. https:\/\/doi.org\/10.2165\/00129785-200101020-00003","journal-title":"Am J Pharmacogenomics"},{"key":"445_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/humu.23351","volume":"39","author":"L Simonetti","year":"2018","unstructured":"Simonetti L, Bruque CD, Fernandez CS, Benavides-Mori B, Delea M, Kolomenski JE et al (2018) CYP21A2 mutation update: comprehensive analysis of databases and published genetic variants. Hum Mutat 39:5\u201322. https:\/\/doi.org\/10.1002\/humu.23351","journal-title":"Hum Mutat"},{"key":"445_CR10","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/sj.gt.3301018","volume":"6","author":"T Tajima","year":"1999","unstructured":"Tajima T, Okada T, Ma XM, Ramsey W, Bornstein S, Aguilera G (1999) Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochromeP450 21-hydroxylase into the adrenal gland of 21-hydroxylase-deficient mice. Gene Ther 6:1898\u20131903. https:\/\/doi.org\/10.1038\/sj.gt.3301018","journal-title":"Gene Ther"},{"key":"445_CR11","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1507\/endocrj.EJ16-0112","volume":"63","author":"Y Naiki","year":"2016","unstructured":"Naiki Y, Miyado M, Horikawa R, Katsumata N, Onodera M, Pang S et al (2016) Extra-adrenal induction of Cyp21a1 ameliorates systemic steroid metabolism in a mouse model of congenital adrenal hyperplasia. Endocr J 63:897\u2013904. https:\/\/doi.org\/10.1507\/endocrj.EJ16-0112","journal-title":"Endocr J"},{"key":"445_CR12","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.celrep.2018.01.003","volume":"22","author":"G Ruiz-Babot","year":"2020","unstructured":"Ruiz-Babot G, Balyura M, Hadjidemetriou I, Ajodha SJ, Taylor DR, Ghataore L, Taylor NF et al (2020) Modeling congenital adrenal hyperplasia and testing interventions for adrenal insufficiency using donor-specific reprogrammed cells. Cell Rep 22:1236\u20131249. https:\/\/doi.org\/10.1016\/j.celrep.2018.01.003","journal-title":"Cell Rep"},{"key":"445_CR13","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41431-020-0653-5","volume":"28","author":"S Baumgartner-Parzer","year":"2020","unstructured":"Baumgartner-Parzer S, Witsch-Baumgartner M, Hoeppner W (2020) EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency. Eur J Hum Genet 28:1341\u20131367. https:\/\/doi.org\/10.1038\/s41431-020-0653-5","journal-title":"Eur J Hum Genet"},{"key":"445_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1515\/jpem.2001.14.1.27","volume":"14","author":"R Mathur","year":"2001","unstructured":"Mathur R, Menon PSN, Kabra M, Goyal RK, Verma IC (2001) Molecular characterization of mutations in Indian children with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Pediatr Endocrinol Metab 14:27\u201335. https:\/\/doi.org\/10.1515\/jpem.2001.14.1.27","journal-title":"J Pediatr Endocrinol Metab"},{"key":"445_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4103\/2230-8210.95679","volume":"16","author":"E Marumudi","year":"2012","unstructured":"Marumudi E, Sharma A, Kulshreshtha B, Khadgawat R, Khurana ML, Ammini AC (2012) Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia. Indian J Endocr Metab 16:384\u2013388. https:\/\/doi.org\/10.4103\/2230-8210.95679","journal-title":"Indian J Endocr Metab"},{"key":"445_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cca.2016.11.037","volume":"464","author":"R Khajuria","year":"2017","unstructured":"Khajuria R, Walia R, Bhansali A, Prasad R (2017) The spectrum of CYP21A2 mutations in congenital adrenal hyperplasia in an Indian cohort. Clin Chim Acta 464:189\u2013194. https:\/\/doi.org\/10.1016\/j.cca.2016.11.037","journal-title":"Clin Chim Acta"},{"key":"445_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/09723757.2017.1383647","volume":"17","author":"R Nageshwari","year":"2017","unstructured":"Nageshwari R, Dhivakar M, Balakrishnan K, Selvan SA, Kumaravel V (2017) Common CYP21A2 gene mutations in South Indian congenital adrenal hyperplasia patients. Int J Hum Genet 17:103\u2013108. https:\/\/doi.org\/10.1080\/09723757.2017.1383647","journal-title":"Int J Hum Genet"},{"key":"445_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12020-020-02494-z","volume":"71","author":"P Gangodkar","year":"2021","unstructured":"Gangodkar P, Khadilkar V, Raghupathy P, Kumar R, Dayal AA, Dayal D et al (2021) Clinical application of a novel next generation sequencing assay for CYP21A2 gene in 310 cases of 21-hydroxylase congenital adrenal hyperplasia from India. Endocrine 71:189\u2013198. https:\/\/doi.org\/10.1007\/s12020-020-02494-z","journal-title":"Endocrine"},{"key":"445_CR19","doi-asserted-by":"publisher","first-page":"104369","DOI":"10.1016\/j.ejmg.2021.104369","volume":"64","author":"L Ravichandran","year":"2021","unstructured":"Ravichandran L, Korula S, Asha HS, Varghese D, Parthiban R, Johnson J et al (2021) Allele-specific PCR and next-generation sequencing based genetic screening for congenital adrenal hyperplasia in India. Eur J Med Genet 64:104369. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104369","journal-title":"Eur J Med Genet"},{"key":"445_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R (2010) Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26:589\u2013595. https:\/\/doi.org\/10.1093\/bioinformatics\/btp698","journal-title":"Bioinformatics"},{"key":"445_CR21","doi-asserted-by":"publisher","first-page":"D64","DOI":"10.1093\/nar\/gks1048","volume":"41","author":"LR Meyer","year":"2013","unstructured":"Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M et al (2013) The UCSC genome browser database: extensions and updates. Nucleic Acids Res 41:D64-69. https:\/\/doi.org\/10.1093\/nar\/gks1048","journal-title":"Nucleic Acids Res"},{"key":"445_CR22","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A et al (2010) The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res 20:1297\u20131303. https:\/\/doi.org\/10.1101\/gr.107524.110","journal-title":"Genome Res"},{"key":"445_CR23","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N et al (2009) The sequence alignment\/map format and SAM tools. Bioinformatics 25:2078\u20132079. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352","journal-title":"Bioinformatics"},{"key":"445_CR24","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/bioinformatics\/btq330","volume":"26","author":"W McLaren","year":"2010","unstructured":"McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F (2010) Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor-PubMed. Bioinformatics 26:2069\u20132070. https:\/\/doi.org\/10.1093\/bioinformatics\/btq330","journal-title":"Bioinformatics"},{"key":"445_CR25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3389\/fendo.2019.00432","volume":"10","author":"D Pignatelli","year":"2019","unstructured":"Pignatelli D, Carvalho BL, Palmeiro A, Barros A, Guerreiro SG, Ma\u00e7ut D (2019) The complexities in genotyping of congenital adrenal hyperplasia: 21-hydroxylase deficiency. Front Endocrinol 10:432. https:\/\/doi.org\/10.3389\/fendo.2019.00432","journal-title":"Front Endocrinol"},{"key":"445_CR26","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/oxfordjournals.jbchem.a123433","volume":"109","author":"Y Higashi","year":"1991","unstructured":"Higashi Y, Hiromasa T, Tanae A, Miki T, Nakura J, Kondo T et al (1991) Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J Biochem 109:638\u2013644. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a123433","journal-title":"J Biochem"},{"key":"445_CR27","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s004390050436","volume":"99","author":"S Lajic","year":"1997","unstructured":"Lajic S, Levo A, Nikoshkov A, Lundberg Y, Partanen J, Wedell A (1997) A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction. Hum Genet 99:704\u2013709. https:\/\/doi.org\/10.1007\/s004390050436","journal-title":"Hum Genet"},{"key":"445_CR28","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1210\/jc.2002-021681","volume":"88","author":"NM Stikkelbroeck","year":"2003","unstructured":"Stikkelbroeck NM, Hoefsloot LH, de Wijs IJ, Otten BJ, Hermus AR, Sistermans EA (2003) CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations. J Clin Endocrinol Metab 88:3852\u20133859. https:\/\/doi.org\/10.1210\/jc.2002-021681","journal-title":"J Clin Endocrinol Metab"},{"key":"445_CR29","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1073\/pnas.1300057110","volume":"110","author":"MI New","year":"2013","unstructured":"New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, Chitayat D et al (2013) Genotype\u2013phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci U S A 110:2611\u20132616. https:\/\/doi.org\/10.1073\/pnas.1300057110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"445_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1530\/EJE-16-0171","volume":"175","author":"DF de Carvalho","year":"2016","unstructured":"de Carvalho DF, Miranda MC, Gomes LG, Madureira G, Marcondes JAM, Billerbeck AEC et al (2016) Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction. Eur J Endocrinol 175:107\u2013116. https:\/\/doi.org\/10.1530\/EJE-16-0171","journal-title":"Eur J Endocrinol"},{"key":"445_CR31","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1210\/jcem.85.3.6441","volume":"85","author":"N Krone","year":"2009","unstructured":"Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP (2009) Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 85:1059\u20131065. https:\/\/doi.org\/10.1210\/jcem.85.3.6441","journal-title":"J Clin Endocrinol Metab"},{"key":"445_CR32","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1172\/JCI115897","volume":"90","author":"PW Speiser","year":"1992","unstructured":"Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT et al (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90:584\u2013595. https:\/\/doi.org\/10.1172\/JCI115897","journal-title":"J Clin Invest"},{"key":"445_CR33","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1210\/jc.2006-2163","volume":"92","author":"RS Ara\u00fajo","year":"2007","unstructured":"Ara\u00fajo RS, Mendonca BB, Barbosa AS, Lin CJ, Marcondes JA, Billerbeck AE et al (2007) Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency. J Clin Endocrinol Metab 92:4028\u20134034. https:\/\/doi.org\/10.1210\/jc.2006-2163","journal-title":"J Clin Endocrinol Metab"},{"key":"445_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6823-11-5","volume":"11","author":"AH Khan","year":"2011","unstructured":"Khan AH, Aban M, Raza J, Haq N, Jabbar A, Moatter T (2011) Ethnic disparity in 21-hydroxylase gene mutations identified in Pakistani congenital adrenal hyperplasia patients. BMC Endocr Disord 11:1\u20136. https:\/\/doi.org\/10.1186\/1472-6823-11-5","journal-title":"BMC Endocr Disord"},{"key":"445_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.steroids.2016.01.007","volume":"108","author":"R Wang","year":"2016","unstructured":"Wang R, Yu Y, Ye J, Han L, Qiu W, Zhang H et al (2016) 21-hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients: genotype\u2013phenotype correlation and identification of nine novel mutations. Steroids 108:47\u201355. https:\/\/doi.org\/10.1016\/j.steroids.2016.01.007","journal-title":"Steroids"},{"key":"445_CR36","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3275\/8648","volume":"36","author":"P Balraj","year":"2013","unstructured":"Balraj P, Lim PG, Sidek H, Wu LL, Khoo ASB et al (2013) Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia. J Endocrinol Invest 36:366\u2013374. https:\/\/doi.org\/10.3275\/8648","journal-title":"J Endocrinol Invest"},{"key":"445_CR37","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1210\/jcem.87.6.8522","volume":"87","author":"S Koyama","year":"2002","unstructured":"Koyama S, Toyoura T, Saisho S, Shimozawa K, Yata J (2002) Genetic analysis of Japanese patients with 21-hydroxylase deficiency: identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21. J Clin Endocrinol Metab 87:2668\u20132673. https:\/\/doi.org\/10.1210\/jcem.87.6.8522","journal-title":"J Clin Endocrinol Metab"},{"key":"445_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1530\/eje.1.01944","volume":"153","author":"V Dolzan","year":"2005","unstructured":"Dolzan V, S\u00f3lyom J, Fekete G, Kov\u00e1cs J, Rakosnikova V, Votava F et al (2005) Mutational spectrum of steroid 21-hydroxylase and the genotype phenotype association in Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol 153:99\u2013106. https:\/\/doi.org\/10.1530\/eje.1.01944","journal-title":"Eur J Endocrinol"},{"key":"445_CR39","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1210\/jcem.78.5.8175971","volume":"78","author":"A Wedell","year":"1994","unstructured":"Wedell A, Thil\u00e9n A, Ritz\u00e9n EM, Stengler B, Luthman H (1994) Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 78:1145\u20131152. https:\/\/doi.org\/10.1210\/jcem.78.5.8175971","journal-title":"J Clin Endocrinol Metab"},{"key":"445_CR40","doi-asserted-by":"publisher","first-page":"E346","DOI":"10.1210\/jc.2012-3343","volume":"98","author":"N Krone","year":"2013","unstructured":"Krone N, Rose IT, Willis DS, Hodson J, Wild SH, Doherty EJ et al (2013) Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE) cohort. J Clin Endocrinol Metab 98:E346\u2013E354. https:\/\/doi.org\/10.1210\/jc.2012-3343","journal-title":"J Clin Endocrinol Metab"},{"key":"445_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ymgme.2005.11.015","volume":"88","author":"A Fri\u00e3es","year":"2006","unstructured":"Fri\u00e3es A, R\u00eago AT, Arag\u00fces JM, Moura LF, Mirante A, Mascarenhas MR et al (2006) CYP21A2 mutations in Portuguese patients with congenital adrenal hyperplasia: identification of two novel mutations and characterization of four different partial gene conversions. Mol Genet Metab 88:58\u201365. https:\/\/doi.org\/10.1016\/j.ymgme.2005.11.015","journal-title":"Mol Genet Metab"},{"key":"445_CR42","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1365-2265.2011.04123.x","volume":"75","author":"R Marino","year":"2011","unstructured":"Marino R, Ramirez P, Galeano J, Perez Garrido N, Rocco C, Ciaccio M, Warman DM et al (2011) Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia. Clin Endocrinol 75:427\u2013435. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04123.x","journal-title":"Clin Endocrinol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-023-00445-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-023-00445-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-023-00445-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T01:14:18Z","timestamp":1684977258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-023-00445-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["445"],"URL":"https:\/\/doi.org\/10.1007\/s42000-023-00445-7","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The questionnaire and methodology for this study was approved by the Human Research Ethics Committee of the Amrita Institute of Medical Sciences, Kochi, Kerala, India. Ethics approval number: IRB- AIMS 2019\u2013051.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants\/legal guardians included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed informed consent forms regarding publication of their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}